Association between lipid fractions and age of first myocardial infarction

Henrik Bødtker1,2, Stine Gunnersen1,3, Kasper Adelborg4

  • 1Institute of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Insights

Low-density-lipoprotein cholesterol (LDL-C) is strongly linked to earlier heart attacks. Controlling LDL-C is crucial for preventing premature myocardial infarction (MI).

Area of Science:

  • Cardiology
  • Lipid Metabolism
  • Public Health

Background:

  • Dyslipidemia is a significant risk factor for early coronary heart disease (CHD).
  • Key lipid fractions, including LDL-C, remnant-C, and HDL-C, are associated with CHD risk.
  • Understanding the differential impact of these lipids on the timing of cardiovascular events is critical.

Purpose of the Study:

  • To compare the association of LDL-C, remnant-C, and HDL-C with the age of first myocardial infarction (MI).
  • To identify which lipid fraction most strongly predicts younger age at first MI.

Main Methods:

  • Multicenter study involving 1744 patients hospitalized with their first MI.
  • Linear regression models were employed to assess independent associations.
  • Lipid levels (LDL-C, remnant-C, HDL-C) were analyzed against age at first MI.

Main Results:

  • Univariate analysis showed significant associations for all three lipid fractions with age at first MI.
  • Multivariate analysis revealed LDL-C as the strongest predictor of younger MI age (–2.5 years per 1 SD increase).
  • Remnant-C showed a weaker association (–0.9 years), while HDL-C had no significant association (0.5 years).

Conclusions:

  • LDL-C is the primary lipid fraction associated with presenting at a younger age with a first MI.
  • These findings underscore the importance of managing and treating LDL-C to prevent premature myocardial infarction.
  • Targeting LDL-C may be a key strategy in reducing the burden of early-onset cardiovascular disease.
Abstract

Related Concept Videos

Inflammation01:38

Inflammation

Overview
61.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
277
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
776
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
637
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
259
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
493